Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-ADCs and PROTACs-Antibody-drug conjugate (ADCs)

Request The Product List ofAntibody-drug conjugate (ADCs) Antibody-drug conjugate (ADCs)

Cat. No. Product Name Information
PC-28465

Trastuzumab deruxtecan

HER2-targeting ADC

Trastuzumab deruxtecan (T-DXd, DS-8201a) is a HER2-targeting antibody-drug conjugate with a topoisomerase I inhibitor exatecan derivative (DX-8951 derivative, DXd) at a drug-to-antibody ratio (DAR) of 7-8, shows potent antitumor activity HER2-positive cancers.

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com